Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Shineway Pharmaceutical Group's quarterly Total Liabilities
increased
from Dec. 2024 (HK$2,748.86 Mil) to Jun. 2025 (HK$2,817.94 Mil) and
increased
from Jun. 2025 (HK$2,817.94 Mil) to Dec. 2025 (HK$2,999.68 Mil).
China Shineway Pharmaceutical Group's annual Total Liabilities
declined
from Dec. 2023 (HK$2,777.35 Mil) to Dec. 2024 (HK$2,748.86 Mil) but then
increased
from Dec. 2024 (HK$2,748.86 Mil) to Dec. 2025 (HK$2,999.68 Mil).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Shineway Pharmaceutical Group Total Liabilities Chart
China Shineway Pharmaceutical Group Total Liabilities Calculation
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Total Liabilities of HK$3,000 Mil mean?
China Shineway Pharmaceutical Group (HKSE:02877) has a Total Liabilities of HK$3,000 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for China Shineway Pharmaceutical Group and its competitors.
Is China Shineway Pharmaceutical Group's Total Liabilities too high?
China Shineway Pharmaceutical Group's current Total Liabilities is HK$3,000 Mil. Overall, China Shineway Pharmaceutical Group has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does China Shineway Pharmaceutical Group's Total Liabilities compare to ZTS?
China Shineway Pharmaceutical Group's Total Liabilities of HK$3,000 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for China Shineway Pharmaceutical Group and its competitors. China Shineway Pharmaceutical Group's current Total Liabilities is HK$3,000 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Shineway Pharmaceutical Group stock overvalued right now?
Based on GuruFocus' analysis, China Shineway Pharmaceutical Group (HKSE:02877) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$6.71, compared to a current price of HK$8.04 — trading 19.7% above its estimated fair value. The current Total Liabilities is HK$3,000 Mil. China Shineway Pharmaceutical Group's overall GF Score™ is 87/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For China Shineway Pharmaceutical Group (HKSE:02877), the current Total Liabilities is HK$3,000 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Shineway Pharmaceutical Group (HKSE:02877) Overvalued in 2026?
Based on GuruFocus' analysis, China Shineway Pharmaceutical Group stock appears to be overvalued.
The current stock price of HK$8.04 is trading 19.7% above its estimated GF Value™ of HK$6.71.
GuruFocus considers China Shineway Pharmaceutical Group to be Modestly Overvalued.
Key valuation signals for HKSE:02877:
Total Liabilities: HK$3,000 Mil
GF Value™: HK$6.71 vs. price of HK$8.04 (19.7% above fair value)
No single metric tells the full story. See the HKSE:02877 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Shineway Pharmaceutical Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, traditional Chinese medicine formula granules, and others, of which injections generate maximum revenue for the company. Geographically, the group operates in the People's Republic of China (PRC) and Hong Kong.
87GF Score
Get the complete analysis for HKSE:02877
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02877 has been successfully added to your 
